Navigation Links
CardioInsight Announces Strategic Financing
Date:11/11/2013

CLEVELAND, Nov. 11, 2013 /PRNewswire-USNewswire/ -- CardioInsight Technologies, Inc., a leading developer of non-invasive electrocardiographic mapping technology, announced today that it has completed a long-term strategic financing that provides the Company with an initial investment of $15 million. This financing provides CardioInsight with the capital necessary to complete ongoing multi-center clinical studies in Europe, further advance product development programs, and secure regulatory clearance for the Company's technology in the United States.

(Logo: http://photos.prnewswire.com/prnh/20121101/DC03452LOGO)

"This is an important financing transaction for the Company as it provides the resources necessary to accelerate and achieve key milestones in the continued evolution of the Company's revolutionary non-invasive, multiple chamber cardiac mapping technology," said Patrick Wethington, President and CEO of CardioInsight. "The ability to complete this transaction is further validation of the strength of the Company's clinical experience with its technology, and a representation of the broad potential this platform offers patients suffering from cardiac arrhythmias and other electrical disorders of the heart."

To date, CardioInsight's electrocardiographic mapping platform has been utilized in over 800 patients in multiple centers and multiple arrhythmia types. Results of these studies have generated nearly 100 publications and presentations in peer-reviewed journals and at international clinical conferences. This includes recent publications in the Journal of the American College of Cardiology (JACC) and presentations during the 2013 Heart Rhythm Society Scientific Sessions describing the Company's recent multi-center, multi-rhythm mapping studies.

Commenting on the transaction, Jay Katarincic, Managing Director of Draper Triangle Ventures, stated, "Not only does this financing support CardioInsight's continued growth, but more importantly is a testament to its ability to develop a world-class product which will change the standard of care in cardiac mapping."

About CardioInsight Technologies Inc.

CardioInsight is a Cleveland, Ohio based medical device company developing a breakthrough platform to improve the mapping of electrical disorders of the heart.  The Company's ECVUE™ system non-invasively generates real-time, whole heart images of the electrical activity on the surface of the heart by combining body surface electrical data with 3D anatomical data. It then reconstructs and displays 3D maps and other useful measures of cardiac electrical activity as if the measurements were taken directly from the surface of the heart.    

For more information, visit CardioInsight's website at www.cardioinsight.com.

Piper Jaffray acted as the exclusive financial adviser to CardioInsight Technologies, Inc., with Oppenheimer, Wolff and Donnelly LLP serving as legal advisor.


'/>"/>
SOURCE CardioInsight Technologies Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. CardioInsight Announces Appointment of Patrick J. Wethington as President & Chief Executive Officer
2. Unilife Announces Supply Agreement with MedImmune for Wearable Injectable Drug Delivery Devices
3. Harwood Feffer LLP Announces Investigation of Santarus, Inc.
4. Stason Pharmaceuticals Inc. announces Kansas City expansion, adds human health capabilities
5. Imprimis Pharmaceuticals, Inc. Announces Its Attendance at the American Academy of Ophthalmology in New Orleans, Nov. 16-19
6. IceCure Medical Ltd. announces treatment of first breast cancer patient using its IceSense3 Cryoablation System at John Wayne Cancer Institute
7. Intrexon Announces Third Quarter Financial Results
8. Misonix, Inc. Announces First Quarter Fiscal Year 2014 Financial Results
9. Pro-Dex, Inc. Announces Fiscal 2014 First Quarter Financial Results Conference Call And Webcast
10. DURECT Announces Proposed Public Offering of Common Stock
11. Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... June 23, 2016  MedSource announced today that ... e-clinical software solution of choice.  This latest decision ... value to their clients by offering a state-of-the-art ... relationship establishes nowEDC as the EDC platform of ... full-service clients.  "nowEDC has long been a preferred ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):